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Abstract
Objectives

Three-dimensional (3D) bioprinting, a method derived from additive manufacturing technology, is a recent and
ongoing trend for the construction of 3D volumetric structures. The purpose of this systematic review is to
summarize evidence from existing human and animal studies assessing the application of 3D printing on bone
repair and regeneration in the craniofacial region.

Data & sources

A rigorous search of all relevant clinical trials and case series was performed, based on specific inclusion and
exclusion criteria. The search was conducted in all available electronic databases and sources, supplemented by
a manual search, in December 2017.

Study selection

43 articles (6 human and 37 animal studies) fulfilled the criteria. The human studies included totally 81 patients
with craniofacial bone defects. Titanium or hydroxylapatite scaffolds were most commonly implanted. The
follow-up period ranged between 6 and 24 months. Bone repair was reported successful in nearly every case,
with minimal complications. Also, animal intervention studies used biomaterials and cells in various
combination, offering insights into the techniques, through histological, biochemical, histomorphometric and
microcomputed tomographic findings. The results in both humans and animals, though promising, are yet to be
verified for clinical impact.

Conclusions

Future research should be focused on well-designed clinical trials to confirm the short- and long- term efficacy of
3D printing strategies for craniofacial bone repair.

Clinical significance

Emerging 3D printing technology opens a new era for tissue engineering. Humans and animals on application of
3D printing for craniofacial bone repair showed promising results which will lead clinicians to investigate more
thoroughly alternative therapeutic methods for craniofacial bone defects.
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1. Introduction
1.1. Background

Three-dimensional (3D) bioprinting technology will play a pivotal role in medicine, offering a promising potential
for bone reconstruction, rehabilitation and regeneration [1,2] and expanding treatment options in many field of
operation [3]. The technique was first described in 1986 by Charles W. Hull under the name of stereolithography
[4]. Since then, many diversified methods and manufacturing techniques have emerged, keeping to the same
fundamental goal - to create intricate 3D structures that mimic the external and internal architecture of the
hosted site [5] and provide essential framework for cell attachment and migration, thereby initiating tissue
regeneration. Alternatively, such a custom-made framework behaves as filling material that rehabilitates the
impaired site; 3D scaffolds, seeded with signaling biomolecules and stem cells, have recently been successfully
transplanted into intended defects [6,7].

There is a variety of terminology for describing 3D printing, including: additive manufacturing (AM), solid
freeform fabrication (SFF) and rapid prototyping (RP). 3D printing technologies involve building a well-defined
3D structure from a computer-aided design (CAD) model using layer by layer arrays [8]. The information for
designing the model is collected by medical imaging technology, mainly computed tomography (CT)
and magnetic resonance imaging (MRI). The acquired raw imaging data are processed and reconstructed as a
volumetric model, which is then transmitted to a 3D bioprinter system. Computer-aided manufacturing (CAM)
tools are used to produce 3D structures, based on the anatomical information of the tissue, to be regenerated
or reconstructed. Finally, 3D printing scaffolds are fabricated, by addition of layered biological materials, with
custom-made external shape and internal porosity, enriched with signaling biomolecules and seeding cells in
several combinations [9,10] (Fig. 1).

Fig. 1. Process of 3D bioprinting.

1.2. Categories of 3D printing systems

The technology of 3D tissue bioprinting comprises three main categories of printing systems: inkjet printers,
laser-assisted printers and microextrusion printers. All these systems share the same coordinated spatial
motion, differing in their bioink dispensing mechanisms. Factors such as surface resolution, biological material
selection and cell viability, need to be taken into account to choose the appropriate printing system [11].
Inkjet printers are also known as drop-on-demand printers; controlled volumes of liquid are delivered to
predefined sites of the substrate via diverse mechanisms [12]. Inkjet printers use thermal, microvalve or acoustic
forces to create and eject droplets of biomaterial through an orifice and thereby to form the tissue substitute.
Thermal inkjet printers use a heating element to separate the liquid into drops [13]. Microvalve inkjet printers

use consecutive opening/closing of a small valve, controlled by an electromagnetic field to expel the liquid [14].
Acoustic inkjet printers use the rapid change in shape of a piezoelectric crystal to generate an impulse in the
liquid [15].
Laser-assisted printers are based on laser-induced forward transfer (LIFT) technology [16]. Typically, they consist
of four components: a pulsed laser beam, a focusing system, a transparent glass slide (coated with laser-energy
absorbing layer), and a layer of biological material/cells. The laser pulse is transferred to the absorbing layer and
is then directed to the layer of biomaterial, generating a high-pressure bubble that propels the biomaterial dropby-drop toward the receiving substrate. Variations of laser-based 3D printers include selective laser sintering
(SLS), stereolithography (SLA) and selective laser melting (SLM) [17].
Microextrusion printers are robotically controlled dispensing systems, consisting of a material-handling print
head, a dispensing system and a stage capable of three dimensional movement [18]. The dispensing system can
be pneumatic or mechanical. Pneumatic extrusion is by use of compressed gas, whereas mechanical dispensing
systems use metallic screws or pistons to push the material out, through a nozzle, on the stage [19]. The latter
dispensing system provides more precise control over the material flow. The layers of the extruded biomaterial
are deposited in continuous struts, rather than droplets, each layer serving as the foundation for the next [11].
Extrusion based variations of 3D printers include fused deposition modeling (FDM) and robocasting/direct ink
writing (DIW) [20] (Fig. 1).

1.3. Objectives

The craniofacial complex comprises regions of diverse structural demands, each requiring appropriate design
and materials for scaffolding, reinforced or not with biomolecules and cells for bone repair. A good
understanding of the manufacturing concepts, biological mechanisms and applications of 3D printing is
necessary for comparison with the traditional methods of bone reconstruction and consideration of such
methods in treatment planning.
In light of the considerable differences among techniques, this systematic review sought to summarize evidence
from existing human and animal studies assessing the application of 3D printing on bone repair and
regeneration in the craniofacial region as well as to identify the success factors and potential complications of
this intervention.

2. Data & sources
2.1. Protocol

The present systematic review was conducted according to the guidelines of the Cochrane Handbook for
Systematic Reviews of Interventions version 5.1.0. [21] and followed the PRISMA (Preferred Reporting Items for
Systematic Reviews and Meta-Analyses) guidelines [22].

2.2. Information sources and literature search strategy

The search strategy was conducted in the electronic databases of MEDLINE, EMBASE, COCHRANE LIBRARY, in
October 2016 and was updated December 2017. Clinical Trials (www.clinicaltrials.gov) and National Research
Register (www.controlled-trials.com) were also searched for unpublished studies. Attempts for personal
communication with the authors were made in cases of incomplete data. Various combinations of the following
keywords were inserted in according to the instructions of each search engine: 3D printing, 3D printed,
bioprinted, bioprinting, 3D scaffold, bone, cranial, craniofacial, facial, craniomaxillofacial, maxilla, mandible,
dental, dentistry. No language, publication status or year restriction was applied. Cross-checking of the included
articles and relevant reviews, as well as a manual web search was conducted for unidentified article. The list of
databases searched with the corresponding strategies is presented in Supplementary Table 1.

2.3. Inclusion/exclusion criteria

The eligible studies were chosen based on inclusion/exclusion criteria that were determined a priori according to
the Participant-Intervention-Comparison-Outcome-Study (PICOS) schema (Table 1).
Table 1. Eligibility criteria used for the study selection.
Category
Inclusion Criteria
Participant
Studies on human participants of any gender with
characteristics
craniofacial bone defects (congenital or acquired)
Animal interventional studies with craniofacial
bone defects (congenital or acquired)
Intervention
Bone repair (reconstruction or/and regeneration)
using 3D printed implanted biomaterials as
scaffolds, solely or in combination with bone grafts,
biomolecules or cell cultures

Comparison
Outcome

Study design

Studies assessing bone repair after using 3D
printed implanted biomaterials
Primary: Evaluation of immediate and long-term
bone repair by histological or radiographic analysis
Secondary: evaluation of serious complications
intraoperatively and postoperatively
(e.g. handling, exposure, infection of the
biomaterial)
Randomized controlled clinical trials
Prospective controlled and uncontrolled clinical
trials
Retrospective controlled and uncontrolled clinical
trials
Case series with number of participants ≥5

Exclusion Criteria
Clinical trials with fewer than five
participants
Defects at sites other than the
craniofacial region
Bone repair using autologous bone,
allogenic bone or xenograft as the
only means of bone repair
3D printing used only for
preoperative analysis or for
simulation of a surgical case
3D printing used only for the
fabrication of surgical splints,
guides, temporary molds, dental
implants or screws
3D printing used only for soft tissue
repair
Studies assessing bone repair by
any other means of reconstruction

Unsupported opinion of expert
Books
Case reports
Case series with number of
participants <5
Observational studies
Narrative or systematic reviews

2.4. Study selection

The resulting studies after applying inclusion/exclusion criteria were first checked for duplicates, then the titles
and abstracts were screened for relevance. The final stage involved retrieving and checking the full texts. The
process was conducted independently by two of the authors (MM, GK) and any conflicts were resolved by
consulting a third author (YR).

2.5. Data extraction

Data extraction was performed independently by two authors (MM, GK) and any discrepancies in data
extraction between the two authors were likewise resolved by a third author (YR). The following data were
recorded:

a. Study’s characteristics (author, year of publication, language, study design)
b. Details of the type of intervention
c. Details of outcome
In every study, the following intervention characteristics were recorded:
a.
b.
c.
d.
e.
f.
g.
h.
i.
j.
k.

Human or animal subjects
Type of animal (for animal studies)
Number of subjects
Site of defect
Origin of defect (congenital or acquired – for human studies)
Type of additive manufacturing
Type of scaffold (degradable or not)
Material of scaffold
Biomolecules or cell seeding
Bone graft
Follow-up period

2.6. Quality assessment of human studies

Initially, a tool was used to rate all the included studies according to their level of evidence, based on the Oxford
Centre for Evidence-based Medicine Levels of Evidence [23].
Afterwards, the Cochrane Collaboration’s Risk of Bias Tool was used to assess the risk of bias in randomized
clinical trials [24]. Seven domains of bias (sequence generation, allocation concealment, blinding of participants
and investigators, blinding of outcome assessors, missing outcome data, selective outcome reporting, other
sources of bias) were estimated as “low”, “unclear” or “high”. A final overall classification was given to each
study as follows:
•
•
•

Low risk of bias (if all domains of the study were at low risk of bias)
Unclear risk of bias (if one or more domains of the study were unclear)
High risk of bias (if one or more domains of the study were at high risk of bias)

The ROBINS-I tool of Cochrane library was used to assess the risk of bias of non-randomized studies [25]. Seven
domains of bias (confounding, selection of participants, classification of intervention, deviations from intended
interventions, missing data, measurement of outcomes, selection of reported result) were estimated as “low”,
“moderate”, “serious”, critical” or “no information”. Each study was finally assessed as follows:
•
•
•
•
•

Low risk of bias (if all domains of the study were at low risk of bias)
Moderate risk of bias (if all domains of the study were at low or moderate risk of bias)
Serious risk of bias (if at least one domain were at serious risk of bias)
Critical risk of bias (if at least one domain were at critical risk of bias)
No information (if there is a lack of information in one or more domains of bias and there is no clear
indication that the study is at serious or critical risk of bias)

Several confounders were considered for the assessment of risk of bias and these were the age of the patient,
the oral hygiene, the initial periodontal health, the nature of the defect, the site of defects and force loading
parameters.
It should be stated that the above tool was not applied to case studies without controls, because the risk of bias
is inherently high and these studies were regarded to have low credibility.

2.7. Quality assessment of animal studies

The animal studies were qualitatively assessed according to the National Centre for the Replacement,
Refinement, and Reduction of Animals in Research (NC3Rs) survey of experimental design and reporting, which
is based on the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines, as modified by Leim et
al. [[26], [27], [28]]. A checklist of domains was applied in all included studies, which were further graded into 3
categories based on the percentage of the essential information they contained: 75% or more of positive
answers (A), 50–74% (B), and less than 50% (C).
The potential bias of the animal studies was assessed using a simplified version of the Cochrane Collaboration’s
risk of bias tool for systematic reviews of interventions [21].

2.8. Outcomes evaluation

The outcome assessment was conducted with regard to the inclusion-exclusion criteria. The primary outcome
was the immediate and long-term bone repair, for the time of observation, assessed by histological or
radiographic evaluation. The secondary outcome was the presence of serious complications, either peri- or postoperatively (i.e. handling, exposure, infection of biomaterial) that may affect the success of the intervention.
Human trials were regarded as successful if the aesthetic and functional result was satisfactory in accordance to
primary and secondary outcomes.

3. Results
The search yielded 838 articles; 803 from the databases and 35 from other sources. One hundred thirty-eight full
texts were retrieved out of these initial results, after eliminating duplicates and checking titles and abstracts.
Only 43 articles fulfilled the predetermined criteria, including 6 human and 37 animal studies. The flow diagram
of the systematic review is presented in Fig. 2.

Fig. 2. Flow diagram of the systematic review.

4. Human studies
4.1. Study selection

All 6 human studies were published in scientific journals during the period 2009–2017, 5 in English and 1 in
Chinese [29]. They consisted of two prospective clinical trials (one randomized and one non-randomized) [30,31]
and four retrospective case series [29,[32], [33], [34]]. The two clinical trials compared 3D printed scaffolds of
different type, biomaterials and with other techniques [30,31].

4.2. Study characteristics

Overall, the studies included 81 patients; 19 patients from the clinical trials and 62 patients from the case series.
The clinical trial included six to 13 patients each [30,31] the case series including eight to 23 patients each
[29,[32], [33], [34]].
Three-dimensional printed biomaterials were most often implanted in mandibular bone defects, followed by
calvarial, maxillary and nasal defects. The vast majority of the defects were acquired after tumor resection or
trauma. Laser printing was most commonly used [31,32,34], followed by inkjet printing [29,33] and
microextrusion [30]. Non-absorbable biomaterials were usually applied. Hydroxyapatite ceramic scaffolds were
most commonly implanted [29,33,34], followed by titanium metal [31,32] and lastly by PCL polymer [30]. Two
studies used a scaffold enhanced with a bone graft [31,33]. The follow-up period ranged between 3 and 12
months. The data extraction of the included human studies is presented in Table 2.

Table 2. Data extraction of human studies.
Study
Level of Study Sample size
evidenc design
e
Goh et 1
RCT
6 (scaffold)
al.
7 (no
2014
scaffold)

Defect
site

Application

AM

Scaffold
material

Material
type

Maxilla,
mandible

Postextraction
ridge
preservation

ME
P

PCL
polymer

Absorbabl
e

Guided bone
regeneration
for ridge
augmentation

LP

Ti metal

Non
absorbable

Sumid
a et al.
2015

3

Clinica
l trial

13 (custommade
scaffold)
13
(commercia
l scaffold)

Mandibl
e

Park et
al.
2016

4

Case
series

21

Calvaria

Bon
e
graft
No

Follow- Succes
up
s
6
month
s

6/6
(100%)

Yes

n/a

13/13
(100%)

Serious
complication
s
Exposure 2/6
(33%)
No bone ingrowth 1/6
(17%)
Experimental
group:
exposure
1/13 (8%),
infection 1/13
(8%) Control
group:
exposure
3/13 (23%),
infection 3/13
(23%)
Infection 1/21
(5%)

Large bone
LP
Ti metal
Non
No
6-24
20/21
defect
absorbable
month (95%)
reconstructio
s
n
Shen
4
Case
23
Mandibl Bone defect
IJP
HA
Absorbabl No
3-10
23/23
None
et al.
series
e
reconstructio
ceramic
e
month (100%)
2014
n
s
Brie et 4
Case
8 (divided in Calvaria
Large bone
LP
HA
Non
No
12
8/8
None
al.
series 3 groups by and
defect
ceramic
absorbable
month (100%)
2013
scaffold
nasal
reconstructio
s
design)
bones
n
Saijo et 4
Case
10
Maxilla,
Bone defect
IJP
HA/a-TCP Non
No
12
10/10
None
al.
series
mandible reconstructio
composit absorbable
month (100%)
2009
n/
e
s
augmentation
Abbreviations: additive manufacturing (AM), inkjet printing (IJP), laser printing (LP), micro-extrusion printing (MEP), polycaprolactone (PCL), titanium
(Ti), hydroxyapatite (HA).

4.3. Risk of bias within studies

The risk of bias of the included randomized and non-randomized clinical trials can be seen in Table 3, Table
4 respectively. According to the Cochrane risk of bias tool, the one identified randomized control trial [30] was
evaluated as having high risk of bias. Although allocation concealment (sealed envelopes) was applied, no
information was given regarding random sequence generation. It is unclear if the participants and personnel
were blinded. As far as the assessors are concerned, no blinding is mentioned for all means of outcome
evaluation, except for radiographic grading. Multiple outcome measurements raise some concerns for other
sources of bias. According to the ROBINS-I tool, the one identified non-randomized trial [31] was evaluated as
having serious risk of bias. Confounding parameters were not adjusted, the classification of intervention was not
well defined and the assessors were aware of the intervention received by the study participants.

Table 3. Risk of bias assessment of identified randomized control trials (RCTs).
AUTHOR OUTCOMES
Sequence
Allocation
Performance
generation
concealment bias
Goh et
al.
2014

Alveolar
ridge
height/width
(evaluation
of bone
resorption)

Unclear
(not possible to
conclude if
randomization
was successful)

Low risk
(sealed
envelopes)

Unclear
(no
information
provided;
blinding of
participants/
personnel is
not easily
possible)

Table 4. Risk of bias assessment of identified non-randomized trials.
AUTHOR OUTCOMES
Bias due to
Bias in
Bias in
confounding
selection of
classification
participants of
into the
intervention
study
Sumida
1.postoperative Serious risk
Low risk
Serious risk
et al.
infection
(reliability or
(all
(intervention
2015
2.operative
validity of
participants
status is not
time
measurements eligible for
well defined)
3.mucosal
of an important target trial
rupture
domain was
were
4.number of
low enough
included in
fixation screws that we expect the study,
serious residual start of
confounding)
follow-up
and start of
intervention
coincided

Detection
bias

Attrition
bias

Selective
reporting

Other
sources of
bias
Unclear
(residual
bias
cannot be
excluded)

Overall
Bias

High risk
(no blinding
mentioned
for all
aspects of
analyses;
outcome is
objective and
blinding is
feasible)

Low risk
(one patient
drop-out
reported;
unlikely to
result in
imbalance)

Low risk
(all reported
results
correspond
to intended
outcome)

Bias due to
deviations
from
intended
interventions
Low risk
(any
deviations
from usual
practice were
unlikely to
impact on the
outcome)

Bias due
to missing
data

Bias in
measurement
of outcomes

Bias in
selection
of reported
result

Overall
Bias

Low risk
(data were
reasonably
complete)

Serious risk
(The outcome
measure was
objective, but
the assessors
were aware of
the
intervention
received by
study
participants)

Low risk
(all
reported
results
correspond
to all
intended
outcomes)

Serious
risk
of bias
(the
study is
judged
to be at
serious
risk of
bias in
at least
one
domain)

High risk of
bias
(the study
is judged to
be at high
risk of bias
in at least
one domain
for this
outcome)

Because of the heterogeneity of the research methods and the intervention characteristics as well as the high
risk of bias of studies, only qualitative analysis of the data of the included studies was performed. Metaanalysis was not feasible.

4.4. Outcomes evaluation

The immediate and long-term bone repair was successful for the time of observation and only one study
reported failure of one case [32]. Regarding serious complications, three studies reported infection and/or
exposure of the biomaterial, and fibrous invasion of the scaffold instead of bone infiltration [[30], [31], [32]].
Nevertheless, all the authors stated that these complications were successfully managed and in no case was the
sustainability of scaffold affected.

5. Animal studies
5.1. Study selection

The 36 included animal studies were published in scientific journals in English, during the period 2007–2017
[[35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56
], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71]]. One study was published as
poster presentation [72].

5.2. Study characteristics

Overall, the studies included 614 animal subjects. Each study included one to 68 animals; with only one study
[53] not reporting the number of the animals used. Rabbits were most commonly used
[40,41,49,50,[54], [55], [56],59,60,62,[68], [69], [70],72], followed by rats [52,53,57,61,62,[64], [65], [66]], mice
[39,44,45,48,58,67], pigs [36,46,47,51], sheep [35,37,42,63] and dogs [38,71].
The vast majority of the defects were calvarial
[35,37,[39], [40], [41], [42],[44], [45], [46], [47], [48], [49], [50],[52], [53], [54], [55], [56], [57], [58], [59], [60], [61
], [62],[64], [65], [66], [67],69,73], followed by mandibular [38,51,57,63,68,70,71] and maxillary [36] ones.
Microextrusion was most commonly used
[[36], [37], [38],42,44,46,47,49,[53], [54], [55],61,64,66,67,[69], [70], [71], [72]], followed by inkjet printing
[39,45,50,56,[58], [59], [60],62,65] and laser printing [35,40,41,48,52,57,68]. Most studies used degradable
biomaterials, with only two exceptions [35,68]. Hydroxyapatite and tricalcium phosphate scaffolds and/or
composites were most commonly implanted
[[36], [37], [38],42,44,47,48,51,[53], [54], [55], [56], [57],59,60,62,64,65,67,[69], [70], [71], [72]]. In
approximately half of the studies, the scaffold was enhanced with biomolecules, such as BMP-2 and/or stem
cells [35,36,39,40,42,[44], [45], [46], [47],[51], [52], [53], [54],57,58,[65], [66], [67], [68]]. Three studies
implanted non-3D printed dermal matrices, enhanced with 3D printed biomolecules [39,45,58]. The total time of
observation, of the included animal studies ranges from 4 to 26 weeks. The data extraction of included animal
studies is presented in Table 5.

Table 5. Data extraction of animal studies.
Author
Animal n
Defect
origin
Cooper et al.
Mouse
68
Calvaria
2010
Herberg et al.
Mouse
19
Calvaria
2014
Ishack et al. 2015 Mouse
15
Calvaria
Keriquel et al.
Mouse
30
Calvaria
2010
Li/Xu et al. 2016
Mouse
42
Calvaria

AM

Scaffold material

dermal matrix (non
3D printed)
IJP
dermal matrix (non
3D printed)
MEP HA/β-TCP composite
LP
n-HA ceramic

Biomolecules & cell
seeding
BMP-2 (3D printed
injection)
BMP-2, SDF-1β, TGF-β1
(3D printed injection)
Dipyridamole, BMP-2
–

MEP PLGA/nHA composite

LV-pdgfb cells

IJP

BMP-2 (3D printed
injection)
Mononuclear cells,
BMP-2
BM stromal cells, DP
stromal cells
BMP-2

IJP

Time of
observation
4 and 8 wks

Serious
complications
None

4 wks

None

2, 4 and 8 wks
1 and 2 wks, 1
and 3 months
2, 3, 4, 5, 6, 7
and 8 wks
4 wks

None
None

8 and 12 wks
5 wks

2 deaths
(unrelated)
None

6 wks

None

–

4, 12 and 24 wks

None

Smith et al. 2012

Mouse

8

Calvaria

Jensen et al. 2013

Pig

16

Calvaria

Jensen et al. 2016

Pig

14

Calvaria

Dadsetan et al.
2015
Ge et al. 2009

Rabbit

10

Calvaria

Rabbit

18

Calvaria

MEP PCL polymer, HA/βTCP composite
LP
PPF polymer with CP
coating
LP
PLGA polymer

Goetz et al. 2013
Kim et al. 2016
Komlev et al.
2015
Shao/Ke et al.
2017
Shim et al. 2014

Rabbit
Rabbit
Rabbit

8
40
5

Calvaria
Calvaria
Calvaria

MEP HA/β-TCP composite
MEP MgP ceramic
IJP
OCP ceramic

–
–
–

8 and 16 wks
4 and 8 wks
6.5 months

1 death
intraoperatively
None
None
None

Rabbit

24

Calvaria

MEP CSi–Mg6 ceramic

–

4, 8 and 12 wks

None

Rabbit

36

Calvaria

BMP-2

4 and 8 wks

None

Simon et al. 2007
Simon et al. 2008
Tamimi et al.
2009
Torres et al. 2011

Rabbit
Rabbit
Rabbit

16
16
8

Calvaria
Calvaria
Calvaria

MEP PCL/PLGA/β-TCP
composite
MEP HA ceramic
IJP
HA ceramic
IJP
TCP ceramic

–
–
–

8 and 16 wks
8 and 16 wks
8 wks

None
None
None

Rabbit

8

Calvaria

IJP

–

8 wks

None

dermal matrix (non
3D printed)
MEP PCL polymer

TCP ceramic

None

Hwang et al. 2017

Rat

32

Calvaria

Kwon et al. 2017

Rat

30

Calvaria

Lee et al. 2012
Li/Chen et al.
2017
Pati et al. 2014

Rat
Rat

12
24

Calvaria
Calvaria

Rat

N/A

Calvaria

Zhao et al. 2015
Tamimi et al.
2014
Adamzyk et al.
2016
Carrel/Moussa et
al. 2016
Haberstroh et al.
2010
Smeets et al.
2016
Carrel/Wiskott et
al. 2016
Shim et al. 2017
Konopnicki et al.
2015
Rockies et al.
2017
Shao/Sun et al.
2017

Rat
Rat,
Rabbit
Sheep

18
6,
16
1

Sheep

Ciocca et al. 2017
Abarrategi et al.
2012

MEP PCL/PLGA/β-TCP
composite
IJP
PLLA/β-TCP
composite
LP
PPF/PLGA composite
MEP PCL polymer

–

2 and 8 wks

None

MG-63 human
osteoblastoma cells
BMP-2, AD stem cells
Platelet-rich plasma

2, 4, 6, 8, 10 and
12 wks
11 wks
4, 8 and 12 wks

None

TM stem cells

8 wks

None

Calvaria
Calvaria

MEP PCL/PLGA/β-TCP
composite
MEP Sr-MBG polymer
IJP
TCP ceramic

–
–

8 wks
8 wks

None
None

Calvaria

LP

12 wks

None

12

Calvaria

MEP HA/α-TCP composite

Mesenchymal stem
cells
–

8 and 16 wks

None

Sheep

9

Calvaria

Chitosan

14 wks

None

Rat

10

None

1

Mesenchymal stem
cells
–

10 and 30 days

Dog

Calvaria,
Mandible
Mandible

MEP PLGA polymer,
TCP/Col composite
LP
PDLLA/β-TCP
composite
MEP HA/α-TCP composite

8 wks

None

Dog
Pig

3
2

Mandible
Mandible

MEP PCL/β-TCP composite
IJP
PCL/β-TCP composite

–
BM progenitor cells

8 wks
8 wks

None
None

Rabbit

12

Mandible

LP

AD stem cells

10 and 20 wks

Rabbit

16

Mandible

–

8 and 16 wks

Sheep
Pig

1
8

Mandible
Maxilla

MEP TCP, CSi, CSi-Mg10,
bredigite (Bred)
ceramic
n/a PCL-HA composite
MEP HA/β-TCP composite

1 case (exposure &
infection)
None

–
Chitosan/BMP-2

3 months
3 months

None
None

PEKK

PEKK

None
None

Abbreviations: additive manufacturing (AM), inkjet printing (IJP), laser printing (LP), micro-extrusion printing
(MEP), polycaprolactone (PCL), hydroxyapatite (HA), tricalcium phosphate (TCP), polylactide-co-glycolide acid
(PLGA), magnesium phosphate (MgP), octacalcium phosphate (OCP), calcium silicate (CSi), poly-l-lactide
(PLLA), propylene fumarate (PPF), poly-d,l-lactide (PDLLA), polyetherketoneketone (PEEK), bone morphogenetic
protein (BMP), stromal cell-derived factor (SDF), transforming growth factor (TGF), dental pulp (DP), adiposederived (AD), turbinate tissue-derived mesenchymal (TM), bone marrow (BM).
Notes: All studies reported bone formation. All materials are degradable except for PEKK. Goetz et al.2013 is a
poster presentation. Table entries sorted by defect origin, and then by animal.

5.3. Quality assessment and risk of bias within studies

Regarding the quality assessment of the included animal studies, most of them were of moderate quality (B),
but five were graded as high (A) and nine as low quality (C). The reasons why most of the studies were graded as
moderate were because outcome assessments and scores were not blinded, sample sizes were not justified,
methods of randomization were not stated, blocking experiments were not performed or no raw data were
available (Supplementary Table 2).
As for the risk of bias, the vast majority of the animal studies were evaluated as having high risk of bias regarding
the sequence generation, the allocation concealment and the blinding parameters. On the contrary, the great
majority of the animal studies were evaluated as having low risk of bias regarding the outcome data and the
selective reporting parameters (Table 6).

Table 6. Risk of bias assessment for animal studies.
Author
Adequate
Risk of Allocation
sequence
bias
concealment
generation
Abarrategi et al. –
H
–
2012
Adamzyk et al.
–
H
–
2016
Carrel et al.
+
L
–
2016a
Carrel et al.
–
H
–
2016b
Ciocca et al.
–
H
–
2017
Cooper et al.
–
H
–
2010
Dadsetan et al. –
H
–
2015
Ge et al. 2009
–
H
–
Goetz et al.
–
H
–
2013
Haberstroh et
+
L
–
al. 2010
Herberg et al.
+
L
–
2014
Hwang et al.
–
H
–
2017
Ishack et al.
–
H
–
2015
Jensen et al.
+
L
–
2014
Jensen et al.
+
L
–
2016
Keriquel et al.
–
H
–
2010
Kim et al. 2016
–
H
–

Risk of
bias

Blinding Risk of
bias

Risk of
bias

H

Incomplete
outcome
data addressed
+

Risk of
bias

H

Free from
selective
reporting
+

H

–

H

+

L

–

L

+

L

H

–

H

+

H

+

L

H

–

H

–

L

+

L

H

–

H

–

L

+

L

H

–

H

–

L

+

L

H

–

H

–

L

+

L

H
H

–
–

H
H

+
+

H
H

–
–

H
H

H

–

H

–

L

+

L

H

–

H

–

L

+

L

H

–

H

+

H

+

L

H

–

H

–

L

+

L

H

–

H

–

L

+

L

H

+

L

–

L

+

L

H

–

H

+

H

+

L

H

–

H

–

L

+

L

L

Komlev et al.
–
H
2015
Konopnichi et
–
H
al. 2015
Kwon et al.
–
H
2017
Lee et al. 2013
–
H
Li et al. 2016
+
L
Li et al. 2017
–
H
Pati et al. 2014
+
L
Roskies et al.
–
H
2017
Shao et al.
+
L
2017a
Shao et al.
–
H
2017b
Shim et al. 2014 +
L
Shim et al. 2017 +
L
Simon et al.
–
H
2017a
Simon et al.
–
H
2017b
Smeets et al.
–
H
2016
Smith et al.
–
H
2012
Tamimi et al.
–
H
2009
Tamimi et al.
–
H
2014
Torres et al.
+
L
2011
Zhao et al. 2015 +
L
Abbreviations: YES (+), NO (-), high (H), low (L).

–

H

–

H

–

L

+

L

–

H

–

H

–

L

+

L

–

H

–

H

–

L

+

L

–
–
–
–
–

H
H
H
H
H

–
–
–
–
–

H
H
H
H
H

–
+
–
–
+

L
H
L
L
H

+
+
+
+
+

L
L
L
L
L

–

H

–

H

+

H

+

L

–

H

–

H

–

L

+

L

–
–
–

H
H
H

–
–
–

H
H
H

–
–
+

L
L
H

+
+
+

L
L
L

–

H

–

H

–

L

+

L

–

H

–

H

–

L

+

L

–

H

–

H

+

H

+

L

–

H

–

H

–

L

+

L

–

H

–

H

–

L

+

L

–

H

–

H

–

L

+

L

–

H

–

H

–

L

+

L

5.4. Outcomes evaluation

The immediate and long-term bone repair was successful for the time of observation among animal studies
demonstrated by histological, biochemical, histomorphometric or microcomputed tomographic findings.
However, some studies reported only bone formation along the scaffold structure and not inside. Only two
studies exhibited complications, related to scaffolds; one incidence of surgical complications [41], one incidence
of minor exposure and infection [68].

6. Discussion
6.1. Overview of existing studies

The present systematic review included only in-vivo studies in order to evaluate the application of the 3D
printed scaffolds in live subjects. For better understanding of these strategies both human and animal studies
were included. The systematic search, based on the inclusion criteria, yielded a limited number of human
studies and a greater number of animal studies. It was decided to include animal studies in the review, since
clinical application of 3D-printing in humans is still scarce in the literature. The human studies reported high
success with limited serious complications, but they were all evaluated as having high risk of bias; the quality
assessment revealed that none fulfilled the requirements of a high-quality study design. Nevertheless, these
studies provide valuable findings for a cutting-edge technology, applied on human beings. On the other hand,
animal studies provide a bridge between in-vitro and human studies, by illustrating significant parameters of the
histological and cellular background of scaffold integration and bone regeneration, even though the quality of
these studies is regarded as moderate. Nevertheless, within limitations and concerns of assessing animal studies
and relating such findings to applications in human beings, it needs to be acknowledged that animal studies
constitute a first in-vivo level of evidence.

6.2. Scaffold materials & combinations

Many types of scaffold materials, alone or combined, have been proposed in an attempted to integrate many
desirable properties, such as osteoinductivity, osteoconductivity, printability, biocompatibility and durability
[6,9].
Bioceramics are the materials most commonly selected. Calcium phosphate compounds (mainly β-TCP) exhibit
favorable biodegradability, chemical bonding with hard tissues and wear resistance, all necessary for loadbearing craniofacial defect sites [74]. The challenge is to maintain a low temperature of sintering in an attempt
to avoid transformation of β-TCP to α-TCP, which is more chemically unstable [75]. In addition, HA has been
deemed a scaffold material for bone repair with outstanding biocompatibility, because of the stoichiometric
similarity to the mineral phase of natural bone [76]. However, it is frequently combined with other bioceramics
or biopolymers due to its inherent weak interaction with the binder liquid during 3D printing process
[77]. Bioglasses are also used, because they show great osteoconductivity and bonding to hard tissue,
nevertheless, they slowly degrade and provoke cytotoxicity on the surrounding tissue [78]. Their major
advantage is that they upregulate osteogenesis and nicely interact with cells [30,31], but they are too brittle for
implantation in load-bearing craniofacial sites [2]. A human study of our review confirms this disadvantage. Saijo
et al. [33] used HA/a-TCP composite scaffolds for maxillomandibular defects and emphasized the difficulties of
composition and fabrication of an ideal scaffold to fulfill strength and dimensional requirements.
Biopolymers have also been widely used. Alginate is usually chosen for cartilage repair, because it
induces chondrocyte proliferation and is compatible with cartilaginous tissue [79,80]. However, it does not
interact with cells and is not suitable for load-bearing applications due to its very low stiffness [11,81].
Biogenic polyphosphates (bio-polyP), such as PCL and PLGA, have remarkable printing resolutions and porosity,
biocompatibility and osteoconductivity [82,83]. Biogenic silica is another biopolymer which is highly

osteoproductive in unfavorable environmental conditions and ensures effective nutrient diffusion in hard
craniofacial tissues with moderate vascularity. It is suitable for cell and proteins adhesion [84,85]. In general, the
superiority of biopolymers over other materials is their prime printability and their ability to efficiently promote
osteogenesis in the scaffold complex.
Metal applications are predominately by titanium. It has incredible biocompatibility and mechanical properties,
such as elastic modulus, fatigue strength and toughness; features which are comparable with natural bone
[86,87]. It is preferable for craniofacial vault reconstruction, where the size of the defect is extensive. It nicely
redefines the shape and aesthetic condition of the affected site. Although non-absorbable, it has the potential
for bone ingrowth, when 3D printed Ti plates incorporate porosity in the periphery, or if 3D printed Ti meshes
have been added to preserve bone grafts [88]. Up to now, the AM technology focused on using ceramics or
polymers for bone tissue engineering, the 3D printing of titanium in microscale has posed considerable
challenges [86].
Composites are the combination of bioceramics with biopolymers to achieve the desirable properties; no single
biomaterial is able to satisfy all the prerequisites for a bone graft material. Composite materials incorporate the
characteristics of their components (e.g. the high wear resistance of ceramics and high toughness of polymers)
[2]. Calcium phosphate/collagen, hydroxyapatite/polyamide, TCP/HA/polyP and others have been proposed for
better chemical and mechanical properties [89,90] as well as controlled porosity and cell interaction [91]. These
materials have been introduced for craniofacial application [92].

6.3. Growth factors & cells

Two strategies have been followed to incorporate biomolecules and cells in scaffolding structures. One method
is to print acellular scaffolds and then seed them with cells through chemical binding. The suitable binder (e.g.
phosphoric acid) should prevent pH-related damage of seeded cells. Alternatively, in bioprinting, the scaffold
material and cells are printed simultaneously. This latter method is superior in precise cell distribution into the
scaffold, however it suffers from low mechanical strength (5 kPa) and temperature- and pressure-related
damage to the cells during printing. These are the main reasons that bioprinting has not yet been used for
human craniofacial tissue regeneration; instead, the method of acellular printing and subsequent cell seeding
seems to be the preferable choice [1]. Cell proliferation should follow a balanced momentum; the viability of the
scaffold can be influenced by insufficient proliferation, whereas too much proliferation can
evoke hyperplasia and apoptosis. Long-term survival and controlled proliferation of cells are essential to achieve
tissue homeostasis of the newly formed bone [6].
Understandably, animal studies have tested a greater variety of materials, alone or in combination with
biomolecules and seeding cells (stem or progenitor cells), scaffolding innovations which have not been
adequately studied in humans. The animal studies show that there is a positive interaction between the scaffold
material and the biomolecules/cells [40,45,47,51]. Noteworthy, the biomolecules/cells can be incorporated in
material rods during layering and not only after microporous fabrication [48]. There is a synergetic stimulation
of bone formation in the scaffolding area through the osteoconductive properties of some scaffold materials
and the osteoinductive properties of the seeding cells [41,42,44,53,67]. Factors, such as TGFβ, BMP-2, MSCs,
BMCs, Chitosan and stromal cells, promote osteogenesis by inducing cell transform towards the bone cell
lineage. Leaving sufficient time for cell cultivation (1–2 weeks) is essential to create a
favorable microenvironment before scaffold implantation [51].

6.4. Capabilities of 3D printing techniques

The in-depth knowledge of 3D printers’ capabilities and their compatibility with scaffolding materials lays the
groundwork for successful application of 3D printing in human and animal subjects. Inkjet printers have high

print speed, low cost, high resolution and compatibility with many biological materials and cells [2]. Also,
printing can be with noncontact and overprinting can be achieved [39]. Nevertheless, some disadvantages, such
as nozzle clogging, alteration of cell viability, uncontrolled droplet size and directionality, should be taken into
account. This type of printer is suitable for low viscosity materials in liquid form and low cell concentrations [93].
Laser printers lack a nozzle, and therefore, the problem of material/cell clogging is avoided [11]. They are
compatible with materials with high range of viscosity, do not have a detrimental effect on cell viability and
achieve high resolution, although at a high cost and a low flow rate [16,94]. The micro-extrusion method is
suitable for bioprinting of a broad array of materials and has the ability to deposit very high cell densities [6].
However, cell viability is lower than the other two types of bioprinting and printing resolution, as well as printing
speed, is often problematic [95].

6.5. Scaffold kinetics & biocompatibility

A controllable degradation rate of the scaffold is required. Ideally, this rate should match the ability of the cells
to replace the biomaterials with their own extracellular matrix (ECM) through a mechanism in which embedded
cells secrete proteases and subsequently produce ECM proteins that define the new tissue [6]. It is also
challenging to have control over degradation byproducts, the whole process should be nontoxic and the
degradation products should rapidly metabolize without producing a detrimental environment to cell viability
and function. The swelling and shrinkage of the biomaterial can unfavorably affect the success of the scaffold,
evoking contamination and inflammation at defect boundaries as well as immune system reaction. Besides this,
biocompatibility should be considered not only as the means to prevent local/systemic effects, but also the
scaffold should have the ability to actively contribute to all biological and functional aspects [96].
The animal studies that use absorbable materials confirm and augment the above findings. Attempts to
fabricate scaffolds that biodegrade in rates comparable to autologous block grafts [38,97] have shown that it is
difficult to duplicate the regenerative ability of native bone (it differs between bones; i.e. ilium has more blood
supply and osteoprogenitors than others) and match degradation of the biomaterial with new bone apposition
[59]. Mostly the higher porosity facilitates more rapid biodegradation [49]. This issue becomes even more
difficult, since the fact that degradation kinetics and mechanical properties are irreversibly proportional (faster
degradation, lower mechanical strength) [44,57]. The high rate ensures fast bone turnover, avoids any
inflammatory process and protects from fibro gingival dehiscence and invasion [57]. On the other hand, scaffold
coverage should be performed without soft tissue tension (the block edges should be rounded) to avoid
exposure and unnecessary degradation by macrophages and osteoclasts [38]. Also, the degradation rate should
not be too fast, but in a physiological rate, to encourage more tissue penetration as well as nutrient exchange
without affecting the scaffold stability [41,42,52].

6.6. Structural scaffold design & mechanical properties

Several parameters of scaffold design are important to fulfill bone in-growth. Regarding the scaffold macrogeometry, the scaffold should precisely fit in the bone defect without having a complicated outline, otherwise it
may not yield to 3D printing [6]. The micro-architecture of the scaffold should be well-structured and with
sufficient porosity and interconnectivity for bone in-growth, cell transportation and nutrient diffusion [11]. The
scaffold should be bioactive by incorporation of mineral phases for osteoinductivity (chemical binders to create
a mineralized structure that can house cells) [1]. Moreover, mechanical properties should be analogous of native
bone. The selection of the biomaterial is driven by the size and load-bearing demands of the affected site.
Human bone exhibits a wide range of physical properties; for example, the human trabecular bone within the
condyle has an elastic modulus ranging between 120–450 MPa and within the mandibular body ranging
between 112–910 MPa [10]. Unfortunately, many 3D printed scaffolds range much lower than these
requirements (10–100 MPa) and we believe that this is the main reason for limited reports of applications in
load-bearing sites.

Perhaps, this is the reason that most of the studies used predominately 3D printed applications in calvaria. In
humans, the case series by Brie et al. [34] compared three hydroxyapatite (HA) ceramic scaffolds, the first
scaffold type was not perfectly adapted to the defect, the second type was perfectly adapted to the defect and
the third had additional peripheral macro-porous areas. They concluded that the hydroxyapatite implants are
well suited to reconstruct large (greater than 25 cm2) or complex calvarial or front-orbital defects, as these
scaffolds eliminate the necessity of bone grafting and facilitate bone reconstruction, giving external shape and
internal porosity. Nevertheless, mimicking the 3D complexity of natural tissues and functionally integrating the
scaffold in bone defects represent significant challenges to which the authors answered with a scaffold with
dense core for mechanical strength and peripheral porosity for bone integration. The case series by Park et al.
[32] used Ti metal scaffolds for calvarial defects with a honeycomb structure to raise the strength-to-weight
ratio. These scaffolds were considered the perfect choice for rehabilitation of large size defects, where the large
amount of required autologous bone affects donor morbidity.
The animal studies emphasized that 3D printing controls the external and the internal architecture of the
material and the scaffold acts as a template for cell colonization and extracellular matrix formation
[36,47,50,52]. External surface topography should be rough enough to increase surface ground for cell
attachment and proliferation as well as to firmly consolidate with the adjustment native bone [35,36,38,63].
Moreover, external surface should act as a barrier for fibrous tissue invasion, since that is a major factor of
scaffold failure [41,46,48]; another way to avoid that is to cover the scaffold with a membrane [38,53,54,64].
Open channels in the periphery of the scaffold increase the migration of osteogenic factors [56]. The internal
surface should be porous enough to facilitate penetration of bone agents and vessels into the scaffold, but to an
extent that the mechanical resistance is not affected [40,71]. It is the fundamentals of 3D printing that
constitute scaffolds as linear porous structures which are controllable in size and patency over the entire length
of the blocks [41,65,66]. These structures are superior to particulate materials, since 3D scaffold provides a
stable environment for multi-level bone augmentation and an organized arrangement of channels/pores for the
progression of a “mineralization front” with its accompanying vascular system [37,51,54,55]. Dead-ends of tubes
and channels increase the concentration of osteogenic factors [56].
Almost all researchers of animal studies pointed out two critical features of scaffold material, important for
scaffold survival. The first one is their porosity (pore size, pore morphology, pore interconnectivity and
distribution) [41,46,49,56,63,72,98]. Most studies conclude that the pores size of scaffolds should be 100–
500 μm to steer the migration/proliferation/differentiation of mesenchymal stem cells, supply with
oxygen/nutrients and to induce the diffusion of factors that trigger inner bone formation [35,37,42,46]. Pore size
below 100 μm promotes chondrogenesis and subsequently ossification, whereas pore size above 100 μm
stimulates direct ossification, but to a size (∼500 μm) that the durability of scaffold is not affected [98]. Very
small size of pores hinders cellular ingrowth and evokes a foreign body response [46]. The second feature
related to scaffold survival is the ability to withstand physical forces. This is an important property when
considering replacement of load-bearing bone and critical-sized defects [61,68,70]. Mechanical strength
depends on the chemical composition, size, shape, surface modification and porosity of the scaffold
[40,47,52,68,69]. Mechanical strength of bone can vary even for the same bone, depending on gender, age and
health condition of the body [98].

6.7. 3D printing applications & topography of bone regeneration

3D printing technology in the craniofacial region has three main application areas: a) rehabilitation of a defect
site with a custom-made prosthesis to restore normal facial appearance, in cases of large bone or soft tissue
defects after trauma and tumor ablation. b) for reconstruction purposes, 3D models, fixation devices, cutting
guides and implanted medical devices can be printed to facilitate and optimize surgical intervention by creating
the essential framework and primary stability for bone grafts. This application is beyond the scope of this

review. c)regeneration aiming to preserve existing bone and stimulate osteogenesis for ultimate bone repair and
normal anatomic and functional restoration [1,11]; this application is still at an initial stage of research. The
researchers seem to emphasize the regeneration potential of the scaffolds, without present long-term follow-up
of scaffold degradation/bone regeneration or in-depth investigation of their clinical sustainability.
The only randomized clinical trial by Goh et al. [30], used polycaprolactone (PCL) polymer scaffold, developed by
a micro-extrusion 3D printer, to preserve maxillary and mandibular alveolar ridge height after tooth extraction in
preparation for final implant restoration, and compared two groups, with or without scaffold. However, the
sample size was too small and underpowered. Bone resorption was noted as evident in both groups, but the
insertion of the 3D bioresorbable scaffold in fresh extraction sockets allowed normal bone healing and better
ridge height maintenance mainly at the mesio-buccal aspect after 6 months as compared to the control group
without the insertion of a scaffold. Nevertheless, the material had not actually resorbed during these months
and that may be the reason for maintenance of alveolar ridge. Interestingly, they suggested the combination of
PCL- tricalcium phosphate (TCP) for favorable degradation and resorption kinetics than PCL alone, without
blocking new bone ingrowth. The positive results of bone formation in animals should be evaluated with
caution, since there are studies which report predominately superficial or irregular bone formation and no or
less bone distribution in the inner structure [38,41,60,62]. The most bone formation was noted at the
interproximal surface of scaffold to adjacent bone [40] and progressively less bone towards the center of the
structure [49,50,55]. However, more bone formation in depth may be expected over time [56,66]. In addition,
the defect geometry plays an important role to successful bone ingrowth; it is preferable to have extensive
surface connection with native bone and thereby proximity with osteoprogenitors [58,59]. The quality of formed
bone seems to be very good with trabecular- and marrow-like structures [49,55,72]. Interestingly, some studies
report that the critical degree of bone filling in the defect area for placement of a dental implant is less than
optimal volume (100%) and the studies report 40–60% of bone filling as adequate for support of a dental
implant [59,62,99,100].

6.8. Operative manipulation & complications

3D printed technology enables the meticulous study, design, fabrication and surgical position of the
scaffold/implant. Virtual planning and fewer surgical steps can be achieved, minimizing operative
and postsurgical complications [101]. The combined findings in human studies illustrate that 3D scanning
technology provides the specific shape of the craniofacial surface and 3D printing accurately replicates the
defect. Surgical maneuvers are easier and operative time is less. The implants can obtain detailed surface design
that enhances the strength-to-weight ratio, tissue integration and bone ingrowth, resulting in high durability,
aesthetics and low inflammatory rate. Dentoalveolar defects require a rapidly resorbing matrix to avoid wound
dehiscence, exposure, and subsequent microbial contamination.
The non-randomized trial by Sumida et al. [31] compared custom-made to prefabricated Ti scaffolds for guided
bone regeneration of mandibular sites for dental implants. Their findings agree with other studies [35,102], in
that the 3D-printed custom-made scaffolds have more ideal shape, better surgical handling, and considerably
less intraoperative time, eliminating postoperative infections and mucosal rupture. The accuracy of the
fabrication procedure leads to improved functional and aesthetic results [103]. The case series by Park et al. [32]
used Ti metal scaffolds for calvarial defects and highlighted the advantages of perfect anatomic alignment and
aesthetic result, shorter operating time and lower risk of infection due to reduced manipulation. Shen et al. [29]
used absorbable HA ceramic scaffolds in mandibular defects after mandibular angle osteotomy and pointed out
the same benefits; the accuracy of the 3D structure ensures successful replacement of the defect, saving
operative time and stimulating postoperative recovery.

6.9. Strength & limitation of the present review

The strengths of the current systematic review include the comprehensive literature search including grey
literature, the robust use of methods for qualitative synthesis and the open provision of the review’s dataset as
an attempt to increase transparency and reproducibility. No language restrictions were applied to avoid
language bias. No publication status or year restriction was applied, thereby maximizing data yield. By including
both human and animal studies, the pool of human studies was enhanced with animal studies, as an effort to
collect information for a recent clinical approach and ongoing technology. Though no unanimously accepted
method for quality assessment of animal studies is available, broad but clinically relevant eligibility criteria were
carefully set in this review to include studies that examined various combinations of biomaterials and types of
3D printing.
Several limitations of the study should be noted. Due to scarcity of randomized and prospective non-randomized
studies, several retrospective case studies were included. Uncontrolled studies with methodological limitations
were part of the review. On the other hand, case series with fewer than five participants which were excluded to
avoid low quality evidence may have interesting findings. Another limitation is that the type and number of
animals as well as the time of observation vary among studies, giving great heterogeneity in many domains.

6.10. 3D printing: Current facts & prospects

The application of 3D printing technology for tissue engineering is not yet universally accepted. 3D printing
strategies on bone repair, especially in the regeneration field, seems to have many obstacles to overcome. In
our mind, ongoing research will overcome surgical difficulties, material manipulation and potential criticisms of
the use of certain regenerative biomolecules in humans. The fabrication of 3D printed scaffolds should be
considered as a promising alternative for bone tissue repair in craniofacial deficiency on the supposition that
several parameters should be taken into account to ensure the success and wide-spread application of 3D
printing bone scaffolding. Firstly, an important factor is the collaboration between medical and engineering
experts, and familiarization with 3D bioengineering abilities. Secondly, the printing devices should scale up to be
faster with high resolution, compatible with biomaterials/living cells and affordable price; nevertheless, the
necessary equipment is expected to have lower cost over the years. Thirdly, the science of biomaterials should
produce compounds in optimal combinations to achieve the desired functional, mechanical and supportive
properties. Direct control over cell proliferation and differentiation as well as well-characterized and
reproducible source of cells are required. Scaffolds should be developed to actively induce vascularization,
innervations, replacement by bone and bone maturation; not just be inert structures. Lastly, human research
should focus on high quality clinical trials, which will provide evidence to assess 3D printing scaffolds over
conventional grafting strategies.
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